[HTML] mdpi.com

[HTML][HTML] Circulating miRNAs in HER2-positive and triple negative breast cancers: potential biomarkers and therapeutic targets

I Gupta, B Rizeq, S Vranic, AEA Moustafa… - International Journal of …, 2020 - mdpi.com
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Save Cite Cited by 12 Related articles Cached

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets.

I Gupta, B Rizeq, S Vranic, AEA Moustafa, H Al Farsi - 2020 - qspace.qu.edu.qa
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite
[HTML] nih.gov

[HTML][HTML] Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets

I Gupta, B Rizeq, S Vranic, AE Al Moustafa… - International Journal of …, 2020 - ncbi.nlm.nih.gov
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets

I Gupta, B Rizeq, S Vranic… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets

I Gupta, B Rizeq, S Vranic, AE Al Moustafa, H Al Farsi - 2020 - agris.fao.org
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite
[PDF] semanticscholar.org

[PDF][PDF] Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets

I Gupta, B Rizeq, S Vranic, AE Al Moustafa… - Int. J. Mol …, 2020 - pdfs.semanticscholar.org
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets.

I Gupta, B Rizeq, S Vranic, AA Moustafa… - International Journal of …, 2020 - europepmc.org
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets.

I Gupta, B Rizeq, S Vranic… - … Journal of Molecular …, 2020 - search.ebscohost.com
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite
[PDF] researchgate.net

[PDF][PDF] Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets

I Gupta, B Rizeq, S Vranic, AE Al Moustafa… - Int. J. Mol. Sci, 2020 - researchgate.net
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite
[PDF] core.ac.uk

[PDF][PDF] Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets

I Gupta, B Rizeq, S Vranic, AE Al Moustafa, H Al Farsi - Int. J. Mol. Sci, 2020 - core.ac.uk
Breast cancer is one of the most prevalent diseases among women worldwide and is highly
associated with cancer-related mortality. Of the four major molecular subtypes, HER2 …
Cite